• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Gilead Sciences

Gilead Sciences

Gilead Sciences Inc GILD

Last Price$86.55Day Change (%)-0.79%
Open Price$87.32Day Change ($)-0.69
Day Range86.32–87.4452-Week Range77.92–120.37

As of Fri 7/22/2016 5:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Ventricular Tachycardia Pipeline Review 2016 Featuring Audentes Therapeutics, Gilead Sciences , HUYA Bioscience, Milestone Pharma & Perrigo Company - Research and Markets

    Global Ventricular Tachycardia Pipeline Review 2016 Featuring Audentes Therapeutics, Gilead Sciences , HUYA Bioscience, Milestone Pharma & Perrigo Company - Research and Markets

  2. PrEP Update: The Facts Speak for Themselves, Notes AHF

    PrEP Update: The Facts Speak for Themselves, Notes AHF

  3. Global Hepatitis B Pipeline Review H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Abivax, Akshaya Bio, GeneCure - Research and Markets

    Global Hepatitis B Pipeline Review H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Abivax, Akshaya Bio, GeneCure - Research and Markets

  4. Gilead Sciences Carving Out a Wider Moat

    StockInvestor editor Matt Coffina and senior biotech analyst Karen Andersen discuss Gilead's growing competitive advantages.

  5. China COPD Drugs Market Growth of 15.56% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: AstraZeneca, GSK, Novartis - Research and Markets

    China COPD Drugs Market Growth of 15.56% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: AstraZeneca, GSK, Novartis - Research and Markets

  6. Gilead's Shot in the Arm

    Morningstar CEO of the Year finalist John Martin's smart capital-allocation decisions have helped drive a 100-fold increase in this biopharmaceutical's stock since he took over in 1996.

  7. A Practical Approach to Tech Investing

    All investments involve risk, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. The information provided in this posting is not a complete analysis of every material fact regarding any country, region, ...

  8. Biotech Boom, or Bubble?

    All investments involve risk, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. The information provided in this posting is not a complete analysis of every material fact regarding any country, region, ...

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.